This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Clobital NM Cream is a combination of three medicines: Clobetasol Topical, Miconazole Topical and Neomycin Topical. Clobetasol Topical is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Miconazole Topical is an antifungal which stops the growth of fungi by preventing them from forming their own protective covering. Neomycin Topical is an antibiotic which kills bacteria by preventing the synthesis of essential proteins, required by bacteria to carry out vital functions.
Clobital NM Cream may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Clobital NM Cream is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby. The baby's skin should not come into direct contact with the treated area of skin. Water-miscible cream/gel is preferred as ointments may expose the baby to harmful effects of Clobital NM Cream via licking.
Clobital NM Cream does not usually affect your ability to drive.
There is limited information available on the use of Clobital NM Cream in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Clobital NM Cream in patients with liver disease. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Clobital NM Cream. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 27th Dec 2017.